Evinacumab-dgnb (Evkeeza; Regeneron Pharmaceuticals, Inc) is the first FDA-approved treatment indicated for children as young as 5 years of age to treat dangerously high levels of LDL-C.
The primary outcome of the study includes an IGA score of 0 or 1, which indicated clear or almost clear skin, respectively, with a reduction, from baseline to week 16.
Blinded arms of the study will continue to evaluate the combination therapy with docetaxel vs docetaxel alone, Merck says.
John Beckner of National Community Pharmacists Association (NCPA) discusses how independent pharmacy plays a new role in primary care with Douglas Hoey, CEO of NCPA.
Sandoz intends to launch the latest Humira biosimilar in the United States on July 1, 2023.
Educating patients, providers improves acceptance, trust as number of approvals, indications grows
The portfolio of oral oncology products has evolved over the past few years and so has the traditional model of distribution.
For the management of ovarian cancer, it has been observed in both cellular and animal models that curcumin suppresses cell proliferation and promotes apoptosis.
New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
The COVID-19 pandemic marginally affected the negative mental health of women more than men, according to a new study.
Purine metabolite xanthine, found in caffeinated beverages and food, affect cell differentiation, and new study results may lead to more knowledge about why diseases such as IBD develop.
Investigators estimate that the effectiveness was higher after 1 or 2 booster doses compared with the primary series alone.
Atea’s drug candidate is considered safe and effective against the viruses that cause COVID-19 and hepatitis C, according to new data presented at ICAR 2023.
Therapy effectively treats cells harboring HR deficiencies, including those of specific types of ovarian, breast cancers.
Clinical decision support, packaging changes can help stop errors related to the HIV medication.
Findings from the ongoing Adult Respiratory Syncytial Virus phase 3 trial suggest RSVPreF3 OA vaccine is effective and safe for individuals aged 60 years and older.
Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.
Most patients used nonproprietary drugs, which may contribute to the reduction of out-of-pocket costs for the treatment of invasive breast cancer.
This month, we spoke with Danielle Roman, PharmD, an oncology clinical pharmacy specialist with Allegheny Health Network.
The treatment shows an acceptable toxicity profile and no new adverse events, according to results of analysis.
Niraparib with abiraterone acetate could be the first dual-action tablet for patients with metastatic castration-resistant prostate cancer and BRCA mutations.
Further research is needed across countries and health systems about PCV13, according to the systematic review published in Taylor & Francis Online.
The kit is now approved in the US to select patients with metastatic prostate cancer who are candidates for the only FDA-approved PSMA-directed radioligand therapy.
Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.
Clostridioides difficile infection can have a significant impact on feelings of depression and anxiety, while worsening quality of life.
Liquid formulations of dabrafenib plus trametinib were also approved, marking the first time a BRAF/MEK inhibitor has been developed in a formulation suitable for patients as young as 1 year of age.
Staff members, especially immunizers, should look at every encounter as an opportunity to educate, support patients.
Indya Wilson, MBA, CPhT, a pharmacy education support specialist at Novant Health Pharmacy Administration, discusses her role in the pharmacy and the benefits of alternative career paths for pharmacy technicians.
MenABCWY combination meets all 11 primary endpoints and shows that it is well tolerated, with a safety profile consistent with MenACWY (Menveo) and MenB (Bexsero).
The risk of long COVID-19 was no worse for patients who had Omicron after the wild-type virus than those just diagnosed with the wild-type.
